 | • レポートコード：D0804-15583 • 出版社/出版日：GlobalInfoResearch / 2020年7月28日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、108ページ • 納品方法：Eメール • 産業分類：医療機器・医療消耗品 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、大腸がん診断の世界市場を広く調査・分析し、今後の市場展望をまとめております。大腸がん診断の種類別市場規模（FOBテスト、CTCテスト、CEAテスト、その他）、用途別市場規模（病院、専門クリニック、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Biocept、Rosetta Genomics、Sysmex Corporation、Cancer Genetics、Illumina、Foundation Medicine、Pathway Genomics Corporation、Epigenomics、Danaher Corporation、Exact Science Corporation ・地域別グローバル市場分析 2015年-2020年 ・大腸がん診断の北米市場（アメリカ、カナダ、メキシコ） ・大腸がん診断のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・大腸がん診断のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・大腸がん診断の南米市場（ブラジル、アルゼンチン） ・大腸がん診断の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：FOBテスト、CTCテスト、CEAテスト、その他 ・用途別分析：病院、専門クリニック、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Colorectal Cancer Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Colorectal Cancer Diagnostics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
Market segmentation
Colorectal Cancer Diagnostics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Colorectal Cancer Diagnostics market has been segmented into:
FOB Tests
CTC Tests
CEA Tests
Others
By Application, Colorectal Cancer Diagnostics has been segmented into:
Hospitals
Specialty Clinics
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Colorectal Cancer Diagnostics market presented in the report. This section sheds light on the sales growth of different regional and country-level Colorectal Cancer Diagnostics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Colorectal Cancer Diagnostics market.
The report offers in-depth assessment of the growth and other aspects of the Colorectal Cancer Diagnostics market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Colorectal Cancer Diagnostics Market Share Analysis
Colorectal Cancer Diagnostics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Colorectal Cancer Diagnostics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Colorectal Cancer Diagnostics sales, revenue and market share for each player covered in this report.
The major players covered in Colorectal Cancer Diagnostics are:
Biocept
Rosetta Genomics
Sysmex Corporation
Cancer Genetics
Illumina
Foundation Medicine
Pathway Genomics Corporation
Epigenomics
Danaher Corporation
Exact Science Corporation
Among other players domestic and global, Colorectal Cancer Diagnostics market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Colorectal Cancer Diagnostics Market Overview
1.1 Product Overview and Scope of Colorectal Cancer Diagnostics
1.2 Classification of Colorectal Cancer Diagnostics by Type
1.2.1 Global Colorectal Cancer Diagnostics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Colorectal Cancer Diagnostics Revenue Market Share by Type in 2019
1.2.3 FOB Tests
1.2.4 CTC Tests
1.2.5 CEA Tests
1.2.6 Others
1.3 Global Colorectal Cancer Diagnostics Market by Application
1.3.1 Overview: Global Colorectal Cancer Diagnostics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Others
1.4 Global Colorectal Cancer Diagnostics Market by Regions
1.4.1 Global Colorectal Cancer Diagnostics Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Colorectal Cancer Diagnostics (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Colorectal Cancer Diagnostics Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Colorectal Cancer Diagnostics Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Colorectal Cancer Diagnostics Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Colorectal Cancer Diagnostics Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Colorectal Cancer Diagnostics Status and Prospect (2015-2025)
2 Company Profiles
2.1 Biocept
2.1.1 Biocept Details
2.1.2 Biocept Major Business
2.1.3 Biocept SWOT Analysis
2.1.4 Biocept Product and Services
2.1.5 Biocept Colorectal Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.2 Rosetta Genomics
2.2.1 Rosetta Genomics Details
2.2.2 Rosetta Genomics Major Business
2.2.3 Rosetta Genomics SWOT Analysis
2.2.4 Rosetta Genomics Product and Services
2.2.5 Rosetta Genomics Colorectal Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.3 Sysmex Corporation
2.3.1 Sysmex Corporation Details
2.3.2 Sysmex Corporation Major Business
2.3.3 Sysmex Corporation SWOT Analysis
2.3.4 Sysmex Corporation Product and Services
2.3.5 Sysmex Corporation Colorectal Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.4 Cancer Genetics
2.4.1 Cancer Genetics Details
2.4.2 Cancer Genetics Major Business
2.4.3 Cancer Genetics SWOT Analysis
2.4.4 Cancer Genetics Product and Services
2.4.5 Cancer Genetics Colorectal Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.5 Illumina
2.5.1 Illumina Details
2.5.2 Illumina Major Business
2.5.3 Illumina SWOT Analysis
2.5.4 Illumina Product and Services
2.5.5 Illumina Colorectal Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.6 Foundation Medicine
2.6.1 Foundation Medicine Details
2.6.2 Foundation Medicine Major Business
2.6.3 Foundation Medicine Product and Services
2.6.4 Foundation Medicine Colorectal Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.7 Pathway Genomics Corporation
2.7.1 Pathway Genomics Corporation Details
2.7.2 Pathway Genomics Corporation Major Business
2.7.3 Pathway Genomics Corporation Product and Services
2.7.4 Pathway Genomics Corporation Colorectal Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.8 Epigenomics
2.8.1 Epigenomics Details
2.8.2 Epigenomics Major Business
2.8.3 Epigenomics Product and Services
2.8.4 Epigenomics Colorectal Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.9 Danaher Corporation
2.9.1 Danaher Corporation Details
2.9.2 Danaher Corporation Major Business
2.9.3 Danaher Corporation Product and Services
2.9.4 Danaher Corporation Colorectal Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.10 Exact Science Corporation
2.10.1 Exact Science Corporation Details
2.10.2 Exact Science Corporation Major Business
2.10.3 Exact Science Corporation Product and Services
2.10.4 Exact Science Corporation Colorectal Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Colorectal Cancer Diagnostics Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Colorectal Cancer Diagnostics Players Market Share
3.2.2 Top 10 Colorectal Cancer Diagnostics Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Colorectal Cancer Diagnostics Revenue and Market Share by Regions
4.2 North America Colorectal Cancer Diagnostics Revenue and Growth Rate (2015-2020)
4.3 Europe Colorectal Cancer Diagnostics Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Colorectal Cancer Diagnostics Revenue and Growth Rate (2015-2020)
4.5 South America Colorectal Cancer Diagnostics Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Colorectal Cancer Diagnostics Revenue and Growth Rate (2015-2020)
5 North America Colorectal Cancer Diagnostics Revenue by Countries
5.1 North America Colorectal Cancer Diagnostics Revenue by Countries (2015-2020)
5.2 USA Colorectal Cancer Diagnostics Revenue and Growth Rate (2015-2020)
5.3 Canada Colorectal Cancer Diagnostics Revenue and Growth Rate (2015-2020)
5.4 Mexico Colorectal Cancer Diagnostics Revenue and Growth Rate (2015-2020)
6 Europe Colorectal Cancer Diagnostics Revenue by Countries
6.1 Europe Colorectal Cancer Diagnostics Revenue by Countries (2015-2020)
6.2 Germany Colorectal Cancer Diagnostics Revenue and Growth Rate (2015-2020)
6.3 UK Colorectal Cancer Diagnostics Revenue and Growth Rate (2015-2020)
6.4 France Colorectal Cancer Diagnostics Revenue and Growth Rate (2015-2020)
6.5 Russia Colorectal Cancer Diagnostics Revenue and Growth Rate (2015-2020)
6.6 Italy Colorectal Cancer Diagnostics Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Colorectal Cancer Diagnostics Revenue by Countries
7.1 Asia-Pacific Colorectal Cancer Diagnostics Revenue by Countries (2015-2020)
7.2 China Colorectal Cancer Diagnostics Revenue and Growth Rate (2015-2020)
7.3 Japan Colorectal Cancer Diagnostics Revenue and Growth Rate (2015-2020)
7.4 Korea Colorectal Cancer Diagnostics Revenue and Growth Rate (2015-2020)
7.5 India Colorectal Cancer Diagnostics Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Colorectal Cancer Diagnostics Revenue and Growth Rate (2015-2020)
8 South America Colorectal Cancer Diagnostics Revenue by Countries
8.1 South America Colorectal Cancer Diagnostics Revenue by Countries (2015-2020)
8.2 Brazil Colorectal Cancer Diagnostics Revenue and Growth Rate (2015-2020)
8.3 Argentina Colorectal Cancer Diagnostics Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Colorectal Cancer Diagnostics by Countries
9.1 Middle East & Africa Colorectal Cancer Diagnostics Revenue by Countries (2015-2020)
9.2 Saudi Arabia Colorectal Cancer Diagnostics Revenue and Growth Rate (2015-2020)
9.3 UAE Colorectal Cancer Diagnostics Revenue and Growth Rate (2015-2020)
9.4 Egypt Colorectal Cancer Diagnostics Revenue and Growth Rate (2015-2020)
9.5 South Africa Colorectal Cancer Diagnostics Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Colorectal Cancer Diagnostics Revenue and Market Share by Type (2015-2020)
10.2 Global Colorectal Cancer Diagnostics Market Forecast by Type (2019-2024)
10.3 FOB Tests Revenue Growth Rate (2015-2025)
10.4 CTC Tests Revenue Growth Rate (2015-2025)
10.5 CEA Tests Revenue Growth Rate (2015-2025)
10.6 Others Revenue Growth Rate (2015-2025)
11 Global Colorectal Cancer Diagnostics Market Segment by Application
11.1 Global Colorectal Cancer Diagnostics Revenue Market Share by Application (2015-2020)
11.2 Colorectal Cancer Diagnostics Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Specialty Clinics Revenue Growth (2015-2020)
11.5 Others Revenue Growth (2015-2020)
12 Global Colorectal Cancer Diagnostics Market Size Forecast (2021-2025)
12.1 Global Colorectal Cancer Diagnostics Market Size Forecast (2021-2025)
12.2 Global Colorectal Cancer Diagnostics Market Forecast by Regions (2021-2025)
12.3 North America Colorectal Cancer Diagnostics Revenue Market Forecast (2021-2025)
12.4 Europe Colorectal Cancer Diagnostics Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Colorectal Cancer Diagnostics Revenue Market Forecast (2021-2025)
12.6 South America Colorectal Cancer Diagnostics Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Colorectal Cancer Diagnostics Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Colorectal Cancer Diagnostics Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Colorectal Cancer Diagnostics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Colorectal Cancer Diagnostics Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Colorectal Cancer Diagnostics Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Colorectal Cancer Diagnostics Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Biocept Corporate Information, Location and Competitors
Table 7. Biocept Colorectal Cancer Diagnostics Major Business
Table 8. Biocept Colorectal Cancer Diagnostics Total Revenue (USD Million) (2017-2018)
Table 9. Biocept SWOT Analysis
Table 10. Biocept Colorectal Cancer Diagnostics Product and Solutions
Table 11. Biocept Colorectal Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Rosetta Genomics Corporate Information, Location and Competitors
Table 13. Rosetta Genomics Colorectal Cancer Diagnostics Major Business
Table 14. Rosetta Genomics Colorectal Cancer Diagnostics Total Revenue (USD Million) (2018-2019)
Table 15. Rosetta Genomics SWOT Analysis
Table 16. Rosetta Genomics Colorectal Cancer Diagnostics Product and Solutions
Table 17. Rosetta Genomics Colorectal Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Sysmex Corporation Corporate Information, Location and Competitors
Table 19. Sysmex Corporation Colorectal Cancer Diagnostics Major Business
Table 20. Sysmex Corporation Colorectal Cancer Diagnostics Total Revenue (USD Million) (2017-2018)
Table 21. Sysmex Corporation SWOT Analysis
Table 22. Sysmex Corporation Colorectal Cancer Diagnostics Product and Solutions
Table 23. Sysmex Corporation Colorectal Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Cancer Genetics Corporate Information, Location and Competitors
Table 25. Cancer Genetics Colorectal Cancer Diagnostics Major Business
Table 26. Cancer Genetics Colorectal Cancer Diagnostics Total Revenue (USD Million) (2017-2018)
Table 27. Cancer Genetics SWOT Analysis
Table 28. Cancer Genetics Colorectal Cancer Diagnostics Product and Solutions
Table 29. Cancer Genetics Colorectal Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Illumina Corporate Information, Location and Competitors
Table 31. Illumina Colorectal Cancer Diagnostics Major Business
Table 32. Illumina Colorectal Cancer Diagnostics Total Revenue (USD Million) (2017-2018)
Table 33. Illumina SWOT Analysis
Table 34. Illumina Colorectal Cancer Diagnostics Product and Solutions
Table 35. Illumina Colorectal Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Foundation Medicine Corporate Information, Location and Competitors
Table 37. Foundation Medicine Colorectal Cancer Diagnostics Major Business
Table 38. Foundation Medicine Colorectal Cancer Diagnostics Total Revenue (USD Million) (2017-2018)
Table 39. Foundation Medicine SWOT Analysis
Table 40. Foundation Medicine Colorectal Cancer Diagnostics Product and Solutions
Table 41. Foundation Medicine Colorectal Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Pathway Genomics Corporation Corporate Information, Location and Competitors
Table 43. Pathway Genomics Corporation Colorectal Cancer Diagnostics Major Business
Table 44. Pathway Genomics Corporation Colorectal Cancer Diagnostics Total Revenue (USD Million) (2017-2018)
Table 45. Pathway Genomics Corporation SWOT Analysis
Table 46. Pathway Genomics Corporation Colorectal Cancer Diagnostics Product and Solutions
Table 47. Pathway Genomics Corporation Colorectal Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Epigenomics Corporate Information, Location and Competitors
Table 49. Epigenomics Colorectal Cancer Diagnostics Major Business
Table 50. Epigenomics Colorectal Cancer Diagnostics Total Revenue (USD Million) (2017-2018)
Table 51. Epigenomics SWOT Analysis
Table 52. Epigenomics Colorectal Cancer Diagnostics Product and Solutions
Table 53. Epigenomics Colorectal Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Danaher Corporation Corporate Information, Location and Competitors
Table 55. Danaher Corporation Colorectal Cancer Diagnostics Major Business
Table 56. Danaher Corporation Colorectal Cancer Diagnostics Total Revenue (USD Million) (2017-2018)
Table 57. Danaher Corporation SWOT Analysis
Table 58. Danaher Corporation Colorectal Cancer Diagnostics Product and Solutions
Table 59. Danaher Corporation Colorectal Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Exact Science Corporation Corporate Information, Location and Competitors
Table 61. Exact Science Corporation Colorectal Cancer Diagnostics Major Business
Table 62. Exact Science Corporation Colorectal Cancer Diagnostics Total Revenue (USD Million) (2017-2018)
Table 63. Exact Science Corporation SWOT Analysis
Table 64. Exact Science Corporation Colorectal Cancer Diagnostics Product and Solutions
Table 65. Exact Science Corporation Colorectal Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Global Colorectal Cancer Diagnostics Revenue (Million USD) by Players (2015-2020)
Table 67. Global Colorectal Cancer Diagnostics Revenue Share by Players (2015-2020)
Table 68. Global Colorectal Cancer Diagnostics Revenue (Million USD) by Regions (2015-2020)
Table 69. Global Colorectal Cancer Diagnostics Revenue Market Share by Regions (2015-2020)
Table 70. North America Colorectal Cancer Diagnostics Revenue by Countries (2015-2020)
Table 71. North America Colorectal Cancer Diagnostics Revenue Market Share by Countries (2015-2020)
Table 72. Europe Colorectal Cancer Diagnostics Revenue (Million USD) by Countries (2015-2020)
Table 73. Asia-Pacific Colorectal Cancer Diagnostics Revenue (Million USD) by Countries (2015-2020)
Table 74. South America Colorectal Cancer Diagnostics Revenue by Countries (2015-2020)
Table 75. South America Colorectal Cancer Diagnostics Revenue Market Share by Countries (2015-2020)
Table 76. Middle East and Africa Colorectal Cancer Diagnostics Revenue (Million USD) by Countries (2015-2020)
Table 77. Middle East and Africa Colorectal Cancer Diagnostics Revenue Market Share by Countries (2015-2020)
Table 78. Global Colorectal Cancer Diagnostics Revenue (Million USD) by Type (2015-2020)
Table 79. Global Colorectal Cancer Diagnostics Revenue Share by Type (2015-2020)
Table 80. Global Colorectal Cancer Diagnostics Revenue Forecast by Type (2021-2025)
Table 81. Global Colorectal Cancer Diagnostics Revenue by Application (2015-2020)
Table 82. Global Colorectal Cancer Diagnostics Revenue Share by Application (2015-2020)
Table 83. Global Colorectal Cancer Diagnostics Revenue Forecast by Application (2021-2025)
Table 84. Global Colorectal Cancer Diagnostics Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Colorectal Cancer Diagnostics Picture
Figure 2. Global Colorectal Cancer Diagnostics Revenue Market Share by Type in 2019
Figure 3. FOB Tests Picture
Figure 4. CTC Tests Picture
Figure 5. CEA Tests Picture
Figure 6. Others Picture
Figure 7. Colorectal Cancer Diagnostics Revenue Market Share by Application in 2019
Figure 8. Hospitals Picture
Figure 9. Specialty Clinics Picture
Figure 10. Others Picture
Figure 11. Global Colorectal Cancer Diagnostics Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Colorectal Cancer Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Colorectal Cancer Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Colorectal Cancer Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Colorectal Cancer Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Colorectal Cancer Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Colorectal Cancer Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Colorectal Cancer Diagnostics Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Colorectal Cancer Diagnostics Revenue Market Share in 2019
Figure 20. Global Top 10 Players Colorectal Cancer Diagnostics Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Colorectal Cancer Diagnostics Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Colorectal Cancer Diagnostics Revenue Market Share by Regions (2015-2020)
Figure 24. Global Colorectal Cancer Diagnostics Revenue Market Share by Regions in 2018
Figure 25. North America Colorectal Cancer Diagnostics Revenue and Growth Rate (2015-2020)
Figure 26. Europe Colorectal Cancer Diagnostics Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Colorectal Cancer Diagnostics Revenue and Growth Rate (2015-2020)
Figure 28. South America Colorectal Cancer Diagnostics Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Colorectal Cancer Diagnostics Revenue and Growth Rate (2015-2020)
Figure 30. North America Colorectal Cancer Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 31. North America Colorectal Cancer Diagnostics Revenue Market Share by Countries in 2019
Figure 32. USA Colorectal Cancer Diagnostics Revenue and Growth Rate (2015-2020)
Figure 33. Canada Colorectal Cancer Diagnostics Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Colorectal Cancer Diagnostics Revenue and Growth Rate (2015-2020)
Figure 35. Europe Colorectal Cancer Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Colorectal Cancer Diagnostics Revenue Market Share by Countries in 2019
Figure 37. Germany Colorectal Cancer Diagnostics Revenue and Growth Rate (2015-2020)
Figure 38. UK Colorectal Cancer Diagnostics Revenue and Growth Rate (2015-2020)
Figure 39. France Colorectal Cancer Diagnostics Revenue and Growth Rate (2015-2020)
Figure 40. Russia Colorectal Cancer Diagnostics Revenue and Growth Rate (2015-2020)
Figure 41. Italy Colorectal Cancer Diagnostics Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Colorectal Cancer Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Colorectal Cancer Diagnostics Revenue Market Share by Countries in 2019
Figure 44. China Colorectal Cancer Diagnostics Revenue and Growth Rate (2015-2020)
Figure 45. Japan Colorectal Cancer Diagnostics Revenue and Growth Rate (2015-2020)
Figure 46. Korea Colorectal Cancer Diagnostics Revenue and Growth Rate (2015-2020)
Figure 47. India Colorectal Cancer Diagnostics Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Colorectal Cancer Diagnostics Revenue and Growth Rate (2015-2020)
Figure 49. South America Colorectal Cancer Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 50. South America Colorectal Cancer Diagnostics Revenue Market Share by Countries in 2019
Figure 51. Brazil Colorectal Cancer Diagnostics Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Colorectal Cancer Diagnostics Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Colorectal Cancer Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Colorectal Cancer Diagnostics Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Colorectal Cancer Diagnostics Revenue and Growth Rate (2015-2020)
Figure 56. UAE Colorectal Cancer Diagnostics Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Colorectal Cancer Diagnostics Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Colorectal Cancer Diagnostics Revenue and Growth Rate (2015-2020)
Figure 59. Global Colorectal Cancer Diagnostics Revenue Share by Type (2015-2020)
Figure 60. Global Colorectal Cancer Diagnostics Revenue Share by Type in 2019
Figure 61. Global Colorectal Cancer Diagnostics Market Share Forecast by Type (2021-2025)
Figure 62. Global FOB Tests Revenue Growth Rate (2015-2020)
Figure 63. Global CTC Tests Revenue Growth Rate (2015-2020)
Figure 64. Global CEA Tests Revenue Growth Rate (2015-2020)
Figure 65. Global Others Revenue Growth Rate (2015-2020)
Figure 66. Global Colorectal Cancer Diagnostics Revenue Share by Application (2015-2020)
Figure 67. Global Colorectal Cancer Diagnostics Revenue Share by Application in 2019
Figure 68. Global Colorectal Cancer Diagnostics Market Share Forecast by Application (2021-2025)
Figure 69. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 70. Global Specialty Clinics Revenue Growth Rate (2015-2020)
Figure 71. Global Others Revenue Growth Rate (2015-2020)
Figure 72. Global Colorectal Cancer Diagnostics Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Colorectal Cancer Diagnostics Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Colorectal Cancer Diagnostics Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Colorectal Cancer Diagnostics Revenue Market Forecast (2021-2025)
Figure 76. Europe Colorectal Cancer Diagnostics Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Colorectal Cancer Diagnostics Revenue Market Forecast (2021-2025)
Figure 78. South America Colorectal Cancer Diagnostics Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Colorectal Cancer Diagnostics Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
転移性大腸がん治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Metastatic Colorectal Cancer Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Metast…- 大腸がん治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Colorectal Cancer Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.7% in the forecast period of 2020 to 2025 and will expected to reach USD 15020 million by 2025, from USD 12490 million in 2019. The Colorec…
- がん検診技術の世界市場 2020年：企業別・地域別・種類別・用途別市場予測 Market Overview The Cancer Screening Technology market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiz…
- がん幹細胞（CSC）の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Cancer Stem Cells (CSCs) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Cancer Stem Cells (C…
- 予測・発症前検査の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Predictive Presymptomatic Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Predictive …